80 related articles for article (PubMed ID: 32635876)
1. Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany.
Plöthner M; Ribbentrop D; Hartman JP; Frank M
Adv Ther; 2016 Sep; 33(9):1461-80. PubMed ID: 27406232
[TBL] [Abstract][Full Text] [Related]
2. Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests.
Tafazoli A; Guggilla RK; Kamel-Koleti Z; Miltyk W
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33802585
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics and big genomic data: from lab to clinic and back again.
Lavertu A; McInnes G; Daneshjou R; Whirl-Carrillo M; Klein TE; Altman RB
Hum Mol Genet; 2018 May; 27(R1):R72-R78. PubMed ID: 29635477
[TBL] [Abstract][Full Text] [Related]
4. Maturing pharmacogenomic factors deliver improvements and cost efficiencies.
Jarvis JP; Megill SE; Silvester P; Shaman JA
Camb Prism Precis Med; 2023; 1():e3. PubMed ID: 38550951
[TBL] [Abstract][Full Text] [Related]
5. Next-generation sequencing in pharmacogenomics - fit for clinical decision support?
Zhou Y; Lauschke VM
Expert Rev Clin Pharmacol; 2024 Mar; 17(3):213-223. PubMed ID: 38247431
[TBL] [Abstract][Full Text] [Related]
6. Precision reimbursement for precision medicine: the need for patient-level decisions between payers, providers and pharmaceutical companies.
Budhdeo S; Ruhl M; Agapow PM; Sharma N; Moss P
Future Healthc J; 2021 Nov; 8(3):e695-e698. PubMed ID: 34888469
[TBL] [Abstract][Full Text] [Related]
7. Direct-to-consumer microbiome testing needs regulation.
The Lancet Gastroenterology Hepatology
Lancet Gastroenterol Hepatol; 2024 Jul; 9(7):583. PubMed ID: 38870959
[No Abstract] [Full Text] [Related]
8. Editorial: Pharmacogenetic landscape in human solid cancers.
Lastraioli E; Colombo F; Frullanti E
Front Oncol; 2023; 13():1343395. PubMed ID: 38260860
[No Abstract] [Full Text] [Related]
9. Acceptability, Feasibility, and Utility of Integrating Pharmacogenetic Testing into a Child Psychiatry Clinic.
Claudio-Campos K; Padrón A; Jerkins G; Nainaparampil J; Nelson R; Martin A; Wiisanen K; Smith DM; Strekalova Y; Marsiske M; Cicali EJ; Cavallari LH; Mathews CA
Clin Transl Sci; 2021 Mar; 14(2):589-598. PubMed ID: 33166056
[TBL] [Abstract][Full Text] [Related]
10. Review and Consensus on Pharmacogenomic Testing in Psychiatry.
Bousman CA; Bengesser SA; Aitchison KJ; Amare AT; Aschauer H; Baune BT; Asl BB; Bishop JR; Burmeister M; Chaumette B; Chen LS; Cordner ZA; Deckert J; Degenhardt F; DeLisi LE; Folkersen L; Kennedy JL; Klein TE; McClay JL; McMahon FJ; Musil R; Saccone NL; Sangkuhl K; Stowe RM; Tan EC; Tiwari AK; Zai CC; Zai G; Zhang J; Gaedigk A; Müller DJ
Pharmacopsychiatry; 2021 Jan; 54(1):5-17. PubMed ID: 33147643
[TBL] [Abstract][Full Text] [Related]
11. Real-World Impact of a Pharmacogenomics-Enriched Comprehensive Medication Management Program.
Jarvis JP; Peter AP; Keogh M; Baldasare V; Beanland GM; Wilkerson ZT; Kradel S; Shaman JA
J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330421
[TBL] [Abstract][Full Text] [Related]
12. Gene-drug pairings for antidepressants and antipsychotics: level of evidence and clinical application.
Murphy LE; Fonseka TM; Bousman CA; Müller DJ
Mol Psychiatry; 2022 Jan; 27(1):593-605. PubMed ID: 34754108
[TBL] [Abstract][Full Text] [Related]
13. The Utility of Pharmacogenetic-Guided Psychotropic Medication Selection for Pediatric Patients: A Retrospective Study.
Ariefdjohan M; Lee YM; Stutzman DL; LeNoue S; Wamboldt MZ
Pediatr Rep; 2021 Jul; 13(3):421-433. PubMed ID: 34449718
[TBL] [Abstract][Full Text] [Related]
14. PARC report: a perspective on the state of clinical pharmacogenomics testing.
Eichmeyer J; Rogers S; Formea CM; Giri J; Jones JS; Schnettler E; Schmidlen T; Glogowski E; Kurz RN
Pharmacogenomics; 2020 Jul; 21(11):809-820. PubMed ID: 32635876
[TBL] [Abstract][Full Text] [Related]
15. PARC report: a health-systems focus on reimbursement and patient access to pharmacogenomics testing.
L Rogers S; Keeling NJ; Giri J; Gonzaludo N; Jones JS; Glogowski E; Formea CM
Pharmacogenomics; 2020 Jul; 21(11):785-796. PubMed ID: 32748688
[TBL] [Abstract][Full Text] [Related]
16. Payer view of personalized medicine.
Pezalla EJ
Am J Health Syst Pharm; 2016 Dec; 73(23):2007-2012. PubMed ID: 27864208
[TBL] [Abstract][Full Text] [Related]
17. Economics of Pharmacogenetic-Guided Treatments: Underwhelming or Overstated?
Hughes DA
Clin Pharmacol Ther; 2018 May; 103(5):749-751. PubMed ID: 29435984
[TBL] [Abstract][Full Text] [Related]
18. The challenges of implementing pharmacogenomic testing in the clinic.
Moyer AM; Caraballo PJ
Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
